/PRNewswire/ Recently, Atantares announced the completion of Pre-A and Pre-A+ financing all around RMB100 million. The Pre-A round is led by Asia Green.
Rgenta Therapeutics has snagged $60 million in a Series A round participated by Highlight Capital, while IDG Capital has led Taichu Biotech‘s $58m Series A.
/PRNewswire/ Degron Therapeutics ("Degron"), a biotechnology company developing a new class of small-molecule medicines that target previously undruggable.
Degron Raises $22 Million to Advance Molecular-Glue-Based Protein Degradation Platform globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.